Pain Management in Autosomal Dominant Polycystic Kidney Disease: Clinical Challenges and a Stepwise Algorithmic Approach.

IF 3.2 Q1 UROLOGY & NEPHROLOGY
Kidney360 Pub Date : 2025-07-07 DOI:10.34067/KID.0000000907
Abdul Hamid Borghol, Fadi George Munairdjy Debeh, Ahmad Ghanem, Marie Therese Bou Antoun, Vineetha Rangarajan, Jonathan Mina, Mohamed Hassanein, Lyle W Baker, Sahil Gupta, Shennen A Mao, Christy L Hunt, Marie C Hogan, Michael A Mao, Fouad T Chebib
{"title":"Pain Management in Autosomal Dominant Polycystic Kidney Disease: Clinical Challenges and a Stepwise Algorithmic Approach.","authors":"Abdul Hamid Borghol, Fadi George Munairdjy Debeh, Ahmad Ghanem, Marie Therese Bou Antoun, Vineetha Rangarajan, Jonathan Mina, Mohamed Hassanein, Lyle W Baker, Sahil Gupta, Shennen A Mao, Christy L Hunt, Marie C Hogan, Michael A Mao, Fouad T Chebib","doi":"10.34067/KID.0000000907","DOIUrl":null,"url":null,"abstract":"<p><p>Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disorder. It is primarily caused by pathogenic variants in the PKD1 or PKD2 genes. This leads to the development of numerous kidney cysts, which can result in kidney enlargement and progression to kidney failure. Pain is a common symptom in ADPKD and can negatively impact quality of life (QOL). This pain is often due to the continuous growth of kidney and liver cysts or associated cystic complications. We present a case of a 29-year-old female with ADPKD who experienced chronic, refractory right-sided flank pain that significantly affected her QOL. Her pain persisted despite taking daily multimodal analgesics and undergoing multiple invasive interventions. She had an unusual asymmetric disease with the right kidney accounting for only 24% of her kidney function. After exhausting all other pain control strategies, she underwent right nephrectomy and partial hepatectomy, which led to substantial improvement in pain and QOL. This review describes the causes, manifestations, and management strategies for abdominal and/or flank pain in ADPKD, including a practical stepwise algorithm to guide clinicians in managing pain and improve QOL of patients with ADPKD. Pain in ADPKD can either be acute or chronic and can lead to significant physical and psychological distress. Effective pain management in ADPKD requires a multidisciplinary approach, incorporating both non-pharmacological and pharmacological interventions such as gabapentin or tolvaptan in select cases. Interventions considered in ADPKD pain control include cyst aspiration with sclerotherapy, celiac plexus blockade, spinal cord stimulation, renal denervation, or nephrectomy.</p>","PeriodicalId":17882,"journal":{"name":"Kidney360","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney360","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34067/KID.0000000907","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disorder. It is primarily caused by pathogenic variants in the PKD1 or PKD2 genes. This leads to the development of numerous kidney cysts, which can result in kidney enlargement and progression to kidney failure. Pain is a common symptom in ADPKD and can negatively impact quality of life (QOL). This pain is often due to the continuous growth of kidney and liver cysts or associated cystic complications. We present a case of a 29-year-old female with ADPKD who experienced chronic, refractory right-sided flank pain that significantly affected her QOL. Her pain persisted despite taking daily multimodal analgesics and undergoing multiple invasive interventions. She had an unusual asymmetric disease with the right kidney accounting for only 24% of her kidney function. After exhausting all other pain control strategies, she underwent right nephrectomy and partial hepatectomy, which led to substantial improvement in pain and QOL. This review describes the causes, manifestations, and management strategies for abdominal and/or flank pain in ADPKD, including a practical stepwise algorithm to guide clinicians in managing pain and improve QOL of patients with ADPKD. Pain in ADPKD can either be acute or chronic and can lead to significant physical and psychological distress. Effective pain management in ADPKD requires a multidisciplinary approach, incorporating both non-pharmacological and pharmacological interventions such as gabapentin or tolvaptan in select cases. Interventions considered in ADPKD pain control include cyst aspiration with sclerotherapy, celiac plexus blockade, spinal cord stimulation, renal denervation, or nephrectomy.

常染色体显性多囊肾病的疼痛管理:临床挑战和逐步算法方法。
常染色体显性多囊肾病(ADPKD)是最常见的遗传性肾脏疾病。它主要是由PKD1或PKD2基因的致病变异引起的。这导致大量肾囊肿的发展,这可能导致肾脏增大和进展为肾衰竭。疼痛是ADPKD的常见症状,可对生活质量(QOL)产生负面影响。这种疼痛通常是由于肾脏和肝脏囊肿的持续生长或相关的囊性并发症。我们提出一个病例29岁女性ADPKD谁经历了慢性,难治性右侧疼痛,显著影响她的生活质量。尽管她每天服用多模式镇痛药并接受多次侵入性干预,但她的疼痛仍然存在。她患有一种罕见的不对称疾病,右肾仅占其肾功能的24%。在用尽所有其他疼痛控制策略后,她接受了右肾切除术和部分肝切除术,这使得疼痛和生活质量得到了实质性的改善。本文综述了ADPKD腹部和/或侧腹疼痛的原因、表现和治疗策略,包括一种实用的逐步算法来指导临床医生管理疼痛和改善ADPKD患者的生活质量。ADPKD患者的疼痛可能是急性的,也可能是慢性的,并可能导致严重的生理和心理困扰。ADPKD的有效疼痛管理需要多学科的方法,结合非药物和药物干预,如加巴喷丁或托伐普坦在某些情况下。ADPKD疼痛控制的干预措施包括囊肿抽吸硬化疗法、乳糜丛阻滞、脊髓刺激、肾去神经支配或肾切除术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Kidney360
Kidney360 UROLOGY & NEPHROLOGY-
CiteScore
3.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信